Portrait of Andrew Phillips

Andrew Phillips

Head of Synthetic Biology


I am currently developing methods and software for understanding and programming information processing in biological systems. One of my long-term aims is to develop a platform for programming biological systems that combines programming languages, compilers, lab automation and machine learning, running at scale on cloud infrastructure.


Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence. Microsoft News, 1 October 2019. Novartis and Microsoft join forces to develop drugs using AI. Financial Times, 1 October 2019. Microsoft makes splash in AI-enabled lab solutions. Nature Biotechnology, 8 July 2019. Microsoft moves into biological computing with Station B. Financial Times, 12 March 2019. Oxford BioMedica Looks to Cut Costs of Gene Therapies With Microsoft Collaboration. Wall Street Journal, 12 March 2019. Microsoft partners with biotech on ‘biological computing’ and cell DNA programming. FierceBiotech, 12 March 2019. Microsoft